Journal of Pediatric Gastroenterology and Nutrition

ByHeart Announces New Data Indicating that its First-of-its-Kind, U.S.-Made Infant Formula Improves Sleep Benefits in Infants, According to Clinical Trial Results

Retrieved on: 
Wednesday, May 3, 2023
Nutrition, Birth weight, Life, Digestion, Tryptophan, Parent, Sleep, Clinical trial, Pediatric gastroenterology, Evaporated milk, Coronavirus Scientific Advisory Board, Translation, Breast milk, Protein, Journal, MD, Journal of Pediatric Gastroenterology and Nutrition, Lactoferrin, Blood, Immune system, Infant, Birth control, Dietary supplement

NEW YORK, May 3, 2023 /PRNewswire/ -- Today, ByHeart, a next-generation baby nutrition company, announced new data from its clinical trial demonstrating that its infant formula improves sleep benefits in infants. The data collected in the clinical trial established that four-month-old infants who consumed ByHeart's infant formula, at this important time during sleep development, woke up less to feed overnight and slept longer between feeds, compared to infants who consumed another infant formula. These findings build on previously announced ease of digestion and tolerability data published in the Journal of Pediatric Gastroenterology and Nutrition. ByHeart's patented protein blend includes lactoferrin and alpha-lactalbumin, the two most abundant proteins in breast milk; the company is the first to include alpha-lactalbumin at breast milk levels in infant formula in the American market. Babies fed ByHeart had significantly fewer spit-ups and softer stools than babies fed another infant formula, and more closely resembled breastfed infants.

Key Points: 
  • The data collected in the clinical trial established that four-month-old infants who consumed ByHeart's infant formula, at this important time during sleep development, woke up less to feed overnight and slept longer between feeds, compared to infants who consumed another infant formula.
  • These findings build on previously announced ease of digestion and tolerability data published in the Journal of Pediatric Gastroenterology and Nutrition.
  • Babies fed ByHeart had significantly fewer spit-ups and softer stools than babies fed another infant formula, and more closely resembled breastfed infants.
  • For more detailed information, additional data, and insights from ByHeart's clinical trial study, visit https://byheart.com .

Clinical Trial Begins to Evaluate Physiological Effects of a Saturated Fat Found in Milk

Retrieved on: 
Thursday, September 23, 2021
Blood, Mortality, Therapy, Clinical trial, Scientific Reports, Pancreatic cancer, Health, Rady, Nutrition, Physiology, Liver cancer, Fatty liver disease, Osteoarthritis, University, Metabolic syndrome, Milk, University of California, San Diego Performance-Based Skills Assessment, SAN, GRAS, Risk, Liver, Science, Global health, Journal, Diet, Journal of Pediatric Gastroenterology and Nutrition, Lists of diseases, Research, Obesity, Pediatric gastroenterology, Institute of Liver and Biliary Sciences, Quality of life, Moyamoya disease, GLOBE, Dietary supplement

SAN DIEGO, Sept. 23, 2021 (GLOBE NEWSWIRE) -- A clinical trial to evaluate the physiological effects of a trace dietary saturated fat found in milk has recently started, led by Dr. Jeffrey Schwimmer at the University of California, San Diego.

Key Points: 
  • SAN DIEGO, Sept. 23, 2021 (GLOBE NEWSWIRE) -- A clinical trial to evaluate the physiological effects of a trace dietary saturated fat found in milk has recently started, led by Dr. Jeffrey Schwimmer at the University of California, San Diego.
  • Mounting scientific evidence supports that pentadecanoic acid (also called C15:0) is the first essential fatty acid to be discovered in 90 years .
  • One large prospective study involving 14,000 people followed over 14 years showed that people who had more odd-chain saturated fatty acids in their diet, including C15:0, had lower mortality.
  • This clinical trial is a key next step toward demonstrating how FA15can replenish individuals critical C15:0 body levels and restore long-term health and wellness, especially as we age.

Globally Acclaimed Pediatrics Nutrition and Allergies Experts Join Else's Advisory Board

Retrieved on: 
Monday, April 12, 2021
Medical specialties, Gastroenterology, Medicine, Journal of Pediatric Gastroenterology and Nutrition, International Scientific Association for Probiotics and Prebiotics, Prebiotic, Hepatology, László Czakó, Alessio Fasano

Until June 2019, she served as the Editor-in-Chief of the Journal of Pediatric Gastroenterology and Nutrition.

Key Points: 
  • Until June 2019, she served as the Editor-in-Chief of the Journal of Pediatric Gastroenterology and Nutrition.
  • Previously, Prof. Szajewska served as a member of the Council and then as the General Secretary of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
  • She also served as the Secretary of the ESPGHAN Committee on Nutrition.
  • Most recently (January 2019), she joined the Board of Directors of the International Scientific Association for Probiotics and Prebiotics.

Alcresta Therapeutics Announces Publication of NASPGHAN Position Paper Recommending RELiZORB® in Children with Chronic Pancreatitis

Retrieved on: 
Tuesday, February 23, 2021
Medical specialties, Pancreas disorders, Clinical medicine, Medicine, Gastroenterology, Medical emergencies, Abdominal pain, Pancreatitis, Journal of Pediatric Gastroenterology and Nutrition, Chronic pancreatitis, Pediatric gastroenterology, Hepatology

The position paper, authored by the NASPGHAN Pancreas Committee, was published in the February issue of the Journal of Pediatric Gastroenterology and Nutrition.

Key Points: 
  • The position paper, authored by the NASPGHAN Pancreas Committee, was published in the February issue of the Journal of Pediatric Gastroenterology and Nutrition.
  • This Committee provides guidance on themedical management of chronic pancreatitis (CP) in children based on existing medical literature.
  • "We are pleased to see a leading nutritional organization of medical professionals recommend use of RELiZORB in patients with chronic pancreatitis.
  • For access to the position paper, visit: Freeman, JA, et al., Medical Management of Chronic Pancreatitis in Children: A Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee.

Kate Farms Releases New Clinical Study Demonstrating Improved Outcomes for Pediatric Patients when using the Company's Plant-Based Nutrition Formulas

Retrieved on: 
Tuesday, February 2, 2021
Medical specialties, Clinical medicine, Health sciences, Pediatrics, Gastroenterology, Pediatric gastroenterology, Constipation, Journal of Pediatric Gastroenterology and Nutrition

An electronic survey, utilizing REDCap, was sent via email to those who had contacted Kate Farms for a formula sample.

Key Points: 
  • An electronic survey, utilizing REDCap, was sent via email to those who had contacted Kate Farms for a formula sample.
  • Pediatric patients who switched to Kate Farms (n=159) reported:
    35-45% reduction in episodes of constipation, bloating, vomiting and diarrhea
    Adherence was defined as consuming > 75% of the formula prescribed.
  • The current abstract published in the Journal of Pediatric Gastroenterology and Nutrition (JPGN), is the pediatric sub-set (n=159) of a larger patient reported outcomes study (n=392) reporting both adult and pediatric outcomes.
  • 4 Cohen, SA., Ramirez, A., Millovich, V. Improved GI tolerance and weight gain in pediatric patients using plant-based enteral formulas.

uBiome Appoints Dr. Alessio Fasano, Division Chief of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children, to its Medical Advisory Board

Retrieved on: 
Wednesday, October 3, 2018
Alessio Fasano, Health, Medicine, Pediatric gastroenterology, Pediatrics, Fasano, Childhood, Prof. (Dr.) Balvir S. Tomar, Journal of Pediatric Gastroenterology and Nutrition

SAN FRANCISCO, Oct. 3, 2018 /PRNewswire-PRWeb/ --uBiome, the leader in microbial genomics, announces the addition of Dr. Alessio Fasano, MD, Division Chief of Pediatric Gastroenterology and Nutrition, W. Allen Walker Chair in Pediatric Gastroenterology and Nutrition, and Director of Mucosal Immunology and Biology Research Center at Massachusetts General Hospital, to its Medical Advisory Board.

Key Points: 
  • SAN FRANCISCO, Oct. 3, 2018 /PRNewswire-PRWeb/ --uBiome, the leader in microbial genomics, announces the addition of Dr. Alessio Fasano, MD, Division Chief of Pediatric Gastroenterology and Nutrition, W. Allen Walker Chair in Pediatric Gastroenterology and Nutrition, and Director of Mucosal Immunology and Biology Research Center at Massachusetts General Hospital, to its Medical Advisory Board.
  • "We are proud to welcome him to our Medical Advisory Board."
  • In 1993, Dr. Fasano founded the University of Maryland School of Medicine Division of Pediatric Gastroenterology and Nutrition.
  • In 2013, he was appointed Division Chief of Pediatric Gastroenterology and Nutrition and acts as Associate Chief for Basic, Clinical and Translational Research at MassGeneral Hospital for Children.